Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Pietsch

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
RSC Chemical Biology|July 11, 2026
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α<sub>2</sub>β<sub>2</sub> holoenzymeChristian Werner, Sophia Eimermacher, Miriam Lauwers, et al.
Journal of Medicinal Chemistry|April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Organic & Biomolecular Chemistry|March 22, 2023
Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumoursFeodor Braun, Marcel Jaschinski, Philipp Täger, et al.
ACS Omega|January 1, 2020
Chromenones as Multineurotargeting Inhibitors of Human EnzymesCarina Lemke, Joscha Christmann, Jiafei Yin, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
RSC Chemical Biology|July 11, 2026
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α<sub>2</sub>β<sub>2</sub> holoenzymeChristian Werner, Sophia Eimermacher, Miriam Lauwers, et al.
Journal of Medicinal Chemistry|April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Organic & Biomolecular Chemistry|March 22, 2023
Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumoursFeodor Braun, Marcel Jaschinski, Philipp Täger, et al.
ACS Omega|January 1, 2020
Chromenones as Multineurotargeting Inhibitors of Human EnzymesCarina Lemke, Joscha Christmann, Jiafei Yin, et al.
Pageof 6